Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

The HSV-1 mechanisms of cell-to-cell spread and fusion are critically dependent on host PTP1B.

Carmichael JC, Yokota H, Craven RC, Schmitt A, Wills JW.

PLoS Pathog. 2018 May 9;14(5):e1007054. doi: 10.1371/journal.ppat.1007054. eCollection 2018 May.

2.

Structural Model of the Tubular Assembly of the Rous Sarcoma Virus Capsid Protein.

Jeon J, Qiao X, Hung I, Mitra AK, Desfosses A, Huang D, Gor'kov PL, Craven RC, Kingston RL, Gan Z, Zhu F, Chen B.

J Am Chem Soc. 2017 Feb 8;139(5):2006-2013. doi: 10.1021/jacs.6b11939. Epub 2017 Jan 27.

PMID:
28094514
3.

Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.

Heyrana KJ, Goh BC, Perilla JR, Nguyen TN, England MR, Bewley MC, Schulten K, Craven RC.

J Virol. 2016 May 27;90(12):5700-5714. doi: 10.1128/JVI.00378-16. Print 2016 Jun 15.

4.

Atomic Modeling of an Immature Retroviral Lattice Using Molecular Dynamics and Mutagenesis.

Goh BC, Perilla JR, England MR, Heyrana KJ, Craven RC, Schulten K.

Structure. 2015 Aug 4;23(8):1414-1425. doi: 10.1016/j.str.2015.05.017. Epub 2015 Jun 25.

5.

Potential role for CA-SP in nucleating retroviral capsid maturation.

England MR, Purdy JG, Ropson IJ, Dalessio PM, Craven RC.

J Virol. 2014 Jul;88(13):7170-7. doi: 10.1128/JVI.00309-14. Epub 2014 Apr 9.

6.

A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition.

Keller PW, Huang RK, England MR, Waki K, Cheng N, Heymann JB, Craven RC, Freed EO, Steven AC.

J Virol. 2013 Dec;87(24):13655-64. doi: 10.1128/JVI.01408-13. Epub 2013 Oct 9.

7.

Lethal mutations in the major homology region and their suppressors act by modulating the dimerization of the rous sarcoma virus capsid protein C-terminal domain.

Dalessio PM, Craven RC, Lokhandwala PM, Ropson IJ.

Proteins. 2013 Feb;81(2):316-25. doi: 10.1002/prot.24188. Epub 2012 Nov 5.

8.

Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.

Butan C, Lokhandwala PM, Purdy JG, Cardone G, Craven RC, Steven AC.

J Virol. 2010 Jul;84(13):6377-86. doi: 10.1128/JVI.00207-10. Epub 2010 Apr 28.

9.

Retroviral capsid assembly: a role for the CA dimer in initiation.

Purdy JG, Flanagan JM, Ropson IJ, Craven RC.

J Mol Biol. 2009 Jun 5;389(2):438-51. doi: 10.1016/j.jmb.2009.04.006. Epub 2009 Apr 8.

10.

Visualization of a missing link in retrovirus capsid assembly.

Cardone G, Purdy JG, Cheng N, Craven RC, Steven AC.

Nature. 2009 Feb 5;457(7230):694-8. doi: 10.1038/nature07724.

11.

Irregular and Semi-Regular Polyhedral Models for Rous Sarcoma Virus Cores.

Heymann JB, Butan C, Winkler DC, Craven RC, Steven AC.

Comput Math Methods Med. 2008;9(3-4):197-210.

12.

Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid.

Lokhandwala PM, Nguyen TL, Bowzard JB, Craven RC.

Virology. 2008 Jun 20;376(1):191-8. doi: 10.1016/j.virol.2008.03.001. Epub 2008 Apr 22.

13.

Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly.

Purdy JG, Flanagan JM, Ropson IJ, Rennoll-Bankert KE, Craven RC.

J Virol. 2008 Jun;82(12):5951-61. doi: 10.1128/JVI.00214-08. Epub 2008 Apr 9.

14.

RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis.

Butan C, Winkler DC, Heymann JB, Craven RC, Steven AC.

J Mol Biol. 2008 Feb 29;376(4):1168-81. doi: 10.1016/j.jmb.2007.12.003. Epub 2007 Dec 8.

15.

Diagnosis and management of toothwear in two children in the same family: a case report.

Craven RC, Mackie LC.

Dent Update. 1998 Jun;25(5):217-8.

PMID:
18170957
16.

Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

Scheifele LZ, Kenney SP, Cairns TM, Craven RC, Parent LJ.

J Virol. 2007 Oct;81(19):10718-28. Epub 2007 Jul 18.

17.

Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein.

Spidel JL, Wilson CB, Craven RC, Wills JW.

J Virol. 2007 Feb;81(3):1288-96. Epub 2006 Nov 8.

18.

Lysines close to the Rous sarcoma virus late domain critical for budding.

Spidel JL, Craven RC, Wilson CB, Patnaik A, Wang H, Mansky LM, Wills JW.

J Virol. 2004 Oct;78(19):10606-16.

19.

The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies.

Perez M, Craven RC, de la Torre JC.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12978-83. Epub 2003 Oct 16.

20.

Widespread West Nile virus activity, eastern United States, 2000.

Marfin AA, Petersen LR, Eidson M, Miller J, Hadler J, Farello C, Werner B, Campbell GL, Layton M, Smith P, Bresnitz E, Cartter M, Scaletta J, Obiri G, Bunning M, Craven RC, Roehrig JT, Julian KG, Hinten SR, Gubler DJ; ArboNET Cooperative Surveillance Group.

Emerg Infect Dis. 2001 Jul-Aug;7(4):730-5.

21.
22.
23.

Rapid SLT gene detection on polyethylene-coacrylic acid film without molecular labels or surface-fouling agents.

Zhang P, Fawcett NC, Evans JA, Hurt T, Harvey KG, Craven RC.

Anal Biochem. 2000 Jul 1;282(2):218-26.

PMID:
10873276
24.

RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Parent LJ, Cairns TM, Albert JA, Wilson CB, Wills JW, Craven RC.

J Virol. 2000 Jan;74(1):164-72.

25.
26.

Relationship between the care index and mean dmft/DMFT.

Worthington HV, Craven RC.

Community Dent Health. 1998 Dec;15(4):248-51.

PMID:
9973725
27.
28.

Rous sarcoma virus direct repeat cis elements exert effects at several points in the virus life cycle.

Simpson SB, Zhang L, Craven RC, Stoltzfus CM.

J Virol. 1997 Dec;71(12):9150-6.

29.

Impact on English dentists of the threat of HIV infection.

Craven RC, O'Brien KD, Bennett EM.

Community Dent Oral Epidemiol. 1996 Jun;24(3):228-9. No abstract available.

PMID:
8871026
30.

Dynamic interactions of the Gag polyprotein.

Craven RC, Parent LJ.

Curr Top Microbiol Immunol. 1996;214:65-94. Review. No abstract available.

PMID:
8791725
31.

Isolation of virus-neutralizing RNAs from a large pool of random sequences.

Pan W, Craven RC, Qiu Q, Wilson CB, Wills JW, Golovine S, Wang JF.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11509-13.

32.

Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

Pepinsky RB, Papayannopoulos IA, Chow EP, Krishna NK, Craven RC, Vogt VM.

J Virol. 1995 Oct;69(10):6430-8.

33.

Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW.

J Virol. 1995 Sep;69(9):5455-60.

34.

Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein.

Craven RC, Leure-duPree AE, Weldon RA Jr, Wills JW.

J Virol. 1995 Jul;69(7):4213-27.

35.

A survey of job stress and job satisfaction among DSAs in the north-west of England.

Craven RC, Blinkhorn AS, Roberts C.

Br Dent J. 1995 Feb 11;178(3):101-4.

PMID:
7873303
36.

A campaign encouraging dental attendance among adolescents in Scotland: the barriers to behaviour change.

Craven RC, Blinkhorn AS, Schou L.

Community Dent Health. 1994 Sep;11(3):131-4.

PMID:
7953930
37.

Identification of a potentially important antigen of Pasteurella haemolytica.

Weldon SK, Mosier DA, Simons KR, Craven RC, Confer AW.

Vet Microbiol. 1994 Jun;40(3-4):283-91.

PMID:
7941293
38.

Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Craven RC, Leure-duPree AE, Erdie CR, Wilson CB, Wills JW.

J Virol. 1993 Oct;67(10):6246-52.

39.
40.

Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.

Wills JW, Craven RC, Weldon RA Jr, Nelle TD, Erdie CR.

J Virol. 1991 Jul;65(7):3804-12.

41.

Form, function, and use of retroviral gag proteins.

Wills JW, Craven RC.

AIDS. 1991 Jun;5(6):639-54. No abstract available.

PMID:
1883539
42.

Cloning and expression of a 30 kDa surface antigen of Pasteurella haemolytica.

Craven RC, Confer AW, Gentry MJ.

Vet Microbiol. 1991 Mar;27(1):63-78.

PMID:
2048283
43.
44.
45.
46.

Chemotaxis of Pseudomonas aeruginosa: involvement of methylation.

Craven RC, Montie TC.

J Bacteriol. 1983 May;154(2):780-6.

47.
48.

Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization.

Montie TC, Craven RC, Holder IA.

Infect Immun. 1982 Jan;35(1):281-8.

49.

Motility and chemotaxis of three strains of Pseudomonas aeruginosa used for virulence studies.

Craven RC, Montie TC.

Can J Microbiol. 1981 Apr;27(4):458-60. No abstract available.

PMID:
6786721
50.

Avoidable Accidents.

Craven RC.

Hospital (Lond 1886). 1911 May 13;50(1295):174. No abstract available.

Supplemental Content

Loading ...
Support Center